2. Pierri M.D., Crescenzi G., Capestro F., Recanatini C., Manso E., D’errico M.M., Prospero E., Barbadoro P., Torracca L. Risk Factors and Impact on Clinical Outcome of Multidrug-Resistant Acinetobacter baumannii Acquisition in Cardiac Surgery Patients. J. Cardiothorac Vasc. Anesth. 2015. pii: S1053-0770(15)00801-0. DOI: 10.1053/j.jvca.2015.08.024.

3. Al-Otaibi F.E., Bukhari E.E., Badr M., Alrabiaa A.A. Prevalence and risk factors of Gramnegative bacilli causing blood stream infection in patients withmalignancy. Saudi Med. J. 2016; 37(9): 979–84. DOI: 10.15537/smj.2016.9.14211

4. Lanini S., Costa A.N., Puro V., Procaccio F., Grossi P.A., Vespasiano F., Ricci A., Vesconi S., Ison M.G., Carmeli Y., Ippolito G; Donor-Recipient Infection (DRIn) Collaborative Study Group. Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwidesurveillance study. PLoS ONE 2015; 10(4): e0123706.

5. Lin M.F., Tsai P.W., Chen J.Y., Lin Y.Y., Lan C.Y. OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii. PLoS ONE 2015; 10(10): e0141107.

6. Kawecki D., Pacholczyk M., Lagiewska B., Sawicka-Grzelak A., Durlik M., Mlynarczyk G., Chmura A. Bacterial and fungal infections in the early post-transplantation period after liver transplantation: etiologic agents and their susceptibility. Transplant. Proc. 2014; 46(8): 2777–81.

7. Ferstl P.G., Filmann N., Brandt C., Zeuzem S., Hogardt M., Kempf V.A., Müller M., Waidmann O., Reinheimer C. The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease. Liver Int. 2017. DOI: 10.1111/liv.13438.

8. Ghajavand H., Esfahani B.N., Havaei S.A., Moghim S., Fazeli H. Molecular identification of Acinetobacter baumannii isolated from intensive care units and their antimicrobial resistance patterns. Adv. Biomed. Res. 2015;.4:.110. DOI: 10.4103/2277-9175.157826.

9. Vasudevan A., Mukhopadhyay A., Li J., Yuen E.G., Tambyah P.A. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients – prospective observational study. BMC Infect. Dis. 2014; 14: 615. DOI: 10.1186/s12879-014-0615-z

10. Perni S., Thenault V., Abdo P., Margulis K., Magdassi S., Prokopovich P. Antimicrobial activity of bone cements embedded with organic nanoparticles. Int. J. Nanomedicine 2015; 10: 6317–29.

11. Lee C.S., Vasoo S., Hu F., Patel R., Doi Y. Klebsiella pneumoniae ST147 coproducing NDM-7 carbapenemase and RmtF 16S rRN Amethyltransferase in Minnesota. J. Clin. Microbiol. 2014; 52(11): 4109–10.

12. Çiçek M., Hasçelik G.I., Müştak H.K., Diker K.S., Şener B. Accurate diagnosis of Pseudomonas luteola in routine microbiology laboratory: on the occasion of two isolates. Mikrobiyol. Bul. 2016; 50(4): 621–4.

13. Rossi F., Girardello R., Cury A.P., Di Gioia T.S., Almeida J.N. Jr, Duarte A.J. Emergence of colistin resistance in the largest university hospital complex of São Paulo, Brazil, over five years. Braz. J. Infect. Dis. 2017; 21(1): 98–101. DOI: 10.1016/j.bjid.2016.09.011

14. Li X., Quan J., Yang Y., Ji J., Liu L., Fu Y., Hua X., Chen Y., Pi B., Jiang Y., Yu Y. Abrp, a new gene, confers reduced susceptibility to tetracycline, glycylcine, chloramphenicol and fosfomycin classes in Acinetobacter baumannii. Eur. J. Clin. Microbiol. Infect. Dis. 2016; 35(8): 1371–5. DOI: 10.1007/s10096-016-2674-0.

15. Lei J., Han S., Wu W., Wang X., Xu J., Han L. Extensively drug-resistant Acinetobacter baumannii outbreak cross-transmitted in an intensive care unit and respiratory intensive care unit. Am. J. Infect. Control. 2016; 44(11): 1280–4. DOI: 10.1016/j.ajic.2016.03.041.

16. Chen Q., Cao H., Lu H., Qiu Z.H., He J.J. Bioprosthetic tricuspid valve endocarditis caused by Acinetobacter baumannii complex, a case report and brief review of the literature. J. Cardiothorac. Surg. 2015; 10: 149. DOI: 10.1186/s13019-015-0377-8.

17. Richmond G.E., Evans L.P., Anderson M.J., Wand M.E., Bonney L.C., Ivens A., Chua K.L., Webber M.A., Sutton J.M., Peterson M.L., Piddock L.J. The Acinetobacter baumannii Two-Component System AdeRS Regulates

18. Genes Required for Multidrug Efflux, Biofilm Formation, and Virulence in a Strain-Specific Manner. mBio 2016; 7(2). pii: e00430-16. DOI: 10.1128/mBio.00430-16.

19. Skowronek P., Wojciechowski A., Leszczyński P., Olszewski P., Sibiński M., Polguj M., Synder M. Can diagnostic ultrasound scanners be a potential vector of opportunistic bacterial infection? Med. Ultrason. 2016; 18(3): 326–31. DOI: 10.11152/mu.2013.2066.183.sko.

20. Bingham J., Abell G., Kienast L., Lerner L., Matuschek B., Mullins W., Parker A., Reynolds N., Salisbury D., Seidel J., Young E., Kirk J. Health care worker hand contamination at critical moments in outpatient care settings. Am. J. Infect. Control. 2016; 44(11): 1198–1202. DOI: 10.1016/j.ajic.2016.04.208

21. Greene C., Vadlamudi G., Eisenberg M.., Foxman B., Koopman J., Xi C. Fomite-fingerpad transfer efficiency (pick-up and deposit) of Acinetobacter baumannii – with and without a latex glove. Am. J. Infect. Control. 2015; 43(9): 928–34. DOI: 10.1016/j.ajic.2015.05.008.

22. Chen C.H., Lin L.C., Chang Y.J., Chen Y.M., Chang C.Y., Huang C.C. Infection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for Institutes. Int. J. Environ Res. Public. Health. 2015; 12(8): 8871–82. DOI: 10.3390/ijerph120808871.

23. Cheng V.C., Chen J.H., Poon R.W., Lee W.M., So S.Y., Wong S.C., Chau P.H., Yip C.C., Wong S.S., Chan J.F., Hung I.F., Ho P.L., Yuen K.Y. Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene. Eur. J. Clin. Microbiol. Infect. Dis. 2015; 34(4): 713–8. DOI: 10.1007/s10096-014-2281-x

24. Ashfaq A., Zhu A., Iyengar A., Wu H., Humphries R., McKinnell J.A., Shemin R., Benharash P. Impact ofan Institutional Antimicrobial Stewardship Program on Bacteriology of Surgical Site Infections in Cardiac Surgery. J. Card. Surg. 2016; 31(6): 367–72. DOI: 10.1111/jocs.12756.

25. Fresnadillo-Martínez M.J.1, García-Merino E., García-Sánchez E., Martín-del Rey Á., Rodríguez-Encinas Á., Rodríguez-Sánchez G., García-Sánchez J.E. Prevention of an outbreak of Acinetobacter baumannii in intensive care units: study of the efficacy ofdifferent mathematical methods. Rev. Esp. Quimioter. 2015; 28(1): 10–20.

26. Shah H.N., Schwartz J.L., Luna G., Cullen D.L. Bathing With 2% Chlorhexidine Gluconate: Evidence and Costs Associated With Central Line-Associated Bloodstream Infections. Crit. Care Nurs. Q. 2016; 39(1): 42–50. DOI: 10.1097/CNQ.0000000000000096.

27. Loveday H.P., Wilson J.A., Pratt R.J., Golsorkhi M., Tingle A., Bak A., Browne J., Prieto J., Wilcox M. Epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J. Hosp. Infect. 2014; 86(Suppl. 1): S1–70. DOI: 10.1016/S0195-6701(13)60012-2.

28. Huang H.P., Chen B., Wang HY., He M. The efficacy of daily chlorhexidine bathing for preventing healthcare-associated infections in adult intensive care units. Korean J. Intern. Med. 2016; 31(6): 1159–170.

29. Cassir N., Thomas G., Hraiech S., Brunet J., Fournier P.E., La Scola B., Papazian L. Chlorhexidine daily bathing: impact on health care-associated infections caused by gram-negative bacteria. Am. J. Infect. Control. 2015; 43(6): 640–3. DOI: 10.1016/j.ajic.2015.02.010.

30. Musuuza J.S., Roberts T.J., Carayon P., Safdar N. Assessing the sustainability of daily chlorhexidine bathing in the intensive care unit of a Veteran’s Hospital by examining nurses’ perspectives and experiences. BMC Infect. Dis. 2017; 17(1): 75. DOI: 10.1186/s12879-017-2180-8

31. Afonso E., Blot K., Blot S. Prevention of hospital-acquired bloodstream infections through chlorhexidine gluconate-impregnated washcloth bathing in intensive care units: a systematic review and meta-analysis of randomised crossover trials. Euro Surveill. 2016; 21(46). pii: 30400. DOI: 10.2807/1560-7917.ES.2016.21.46.30400.

32. Cassir N., Papazian L., Fournier P.E., Raoult D., La Scola B. Insights into bacterial colonization of intensive care patients’ skin: the effect of chlorhexidine daily bathing. Eur. J. Clin. Microbiol. Infect Dis. 2015; 34(5): 999–1004. DOI: 10.1007/s10096-015-2316-y.

33. Denny J., Munro C.L. Chlorhexidine Bathing Effects on Health-Care-Associated Infections. Biol. Res. Nurs. 2017; 19(2): 123–36. DOI: 10.1177/1099800416654013.

34. Swan J.T., Ashton C.M., Bui L.N., Pham V.P., Shirkey B.A, Blackshear J.E., Bersamin J.B., Pomer R.M., Johnson M.L., Magtoto A.D., Butler M.O., Tran S.K., Sanchez L.R., Patel J.G., Ochoa R.A. Jr, Hai S.A., Denison K.I., Graviss E.A., Wray N.P.. Effect of Chlorhexidine Bathing Every Other Day on Prevention of Hospital-Acquired Infections in the Surgical ICU: A Single-Center, Randomized Controlled Trial. Crit. Care Med. 2016; 44(10): 1822–32. DOI: 10.1097/CCM.0000000000001820.

35. Duszyńska W., Adamik B., Lentka-Bera K., Kulpa K., Nieckula-Schwarz A., Litwin A., Stróżecki Ł., Kübler A. Effect of universal chlorhexidine decolonisation on the infection rate in intensive care patients. Anaesthesiol. Intensive Ther. 2017; 49(1): 28–33. DOI: 10.5603/AIT.2017.0007.

36. Gupta T.T., Karki S.B., Matson J.S., Gehling D.J., Ayan H. Sterilization of Biofilm on a Titanium Surface Using a Combination of Nonthermal Plasma and Chlorhexidine Digluconate. Biomed. Res. Int. 2017; 6085741. DOI: 10.1155/2017/6085741

37. Романова Н.И., Горская Е.М., Есенова Н.М., Захаревич В.М., Саитгареев Р.Ш., Габриэлян Н.И.. Микрофлора внешней среды как угроза развития инфекционной патологии у пациентов после ортотопической трансплантации сердца. Медицинский алфавит 2016; 1(6): 47–55.

38. Габриэлян Н.И., Арефьева Л.И., Горская Е.М., Драбкина И.В., Есенова Н.М., Романова Н.И., Федорова Л.С. К проблеме предупреждения госпитальных инфекций в условиях развития антибиотикорезистентности патогенов. Дезинфекционное дело 2015; (2): 25–31.

39. Габриэлян Н.И., Горская Е.М., Драбкина И.В., Савостьянова О.А., Ромашкина Л.Ю., Захаревич В.М., Саитгареев Р.Ш. Бактериемии госпитального периода после кардиохирургических операций. Российский медицинский журнал 2015; 21(5): 17–21